Home » Topics » Regulatory

Regulatory
RSS

Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe

April 23, 2013

FDA approves beta-blocker-free, fixed-combination therapy for glaucoma

April 23, 2013

Hydrea approved for essential thrombocythemia and polycythemia vera in Japan

April 4, 2013

Neoral receives an additional indication approval in Japan

April 3, 2013

Istradefylline approved in Japan for Parkinson's disease

April 3, 2013

Invokana approved by the FDA for type 2 diabetes

April 2, 2013

Eisai obtains FDA approval for new formulation of AcipHex

April 2, 2013

FDA approves Biogen Idec's Tecfidera as first-line oral treatment for MS

March 28, 2013

FDA approves botulism antitoxin manufactured by Cangene

March 27, 2013

Chugai gains Japanese approval for subcutaneous formulation of Actemra

March 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 15, 2025.
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
Merck’s MK-2214 shows potential to slow Alzheimer’s pathology
BioWorld Science
Abnormal tau aggregation is a hallmark of Alzheimer’s disease (AD) and a major contributor to neurodegeneration, synaptic dysfunction, and progressive functional...
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...